Johnson & Johnson (JNJ) Balance Sheet

NYSE: JNJAssets, liabilities, debt and equity over 10 years.

JNJ balance sheet, 2025

December 31, 2025 · U.S. dollars

$199.21B assets = $117.67B liabilities + $81.54B equity

What it owns$199.21BCash & ST investments: $20.10B (10.1%)$20.10BReceivables: $17.18B (8.6%)Receivables $17.18BInventory: $14.19B (7.1%)Inventory $14.19BOther current: $4.15B (2.1%)PP&E: $23.17B (11.6%)PP&E$23.17B · 12%Goodwill & intangibles: $99.17B (49.8%)Goodwill & intangibles$99.17B · 50%Other non-current: $21.24B (10.7%)Other non-current $21.24B=How it is financed$199.21BCurrent liabilities: $54.13B (27.2%)Current liabilities$54.13B · 27%Long-term debt: $39.44B (19.8%)Long-term debt$39.44B · 20%Other LT liabilities: $24.10B (12.1%)Other LT liabilities$24.10B · 12%Shareholders’ equity: $81.54B (40.9%)Shareholders’ equity$81.54B · 41%

Both columns are drawn to the same scale: what JNJ owns equals what it owes plus shareholders’ equity. Hover a block for its value.

JNJ financial health

Current ratio1.03
Adequate · current assets cover current liabilities 1.03×
Debt / equity0.59
Moderate leverage · $0.59 of debt for each $1 of equity
Equity / assets40.9%
Equity-funded · of assets funded by shareholders
Cash / debt41.9%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles49.8%
Acquisition-heavy · of total assets

Descriptive bands, not a rating. Fiscal 2025.

JNJ balance sheet trends, 2016–2025

Johnson & Johnson balance sheet trends
MetricTrendThenLatestChange
Total assets$141.21B2016$199.21B2025+3.9%/yr
Total liabilities$70.79B2016$117.67B2025+5.8%/yr
Shareholders’ equity$70.42B2016$81.54B2025+1.6%/yr
Cash & short-term investments$41.91B2016$20.10B2025−7.8%/yr
Total debt$27.13B2016$47.93B2025+6.5%/yr
Net cash (debt)$14.78B2016−$27.83B2025−$42.6B
Working capital$38.74B2016$1.50B2025−$37.2B
Book value per share$25.252016$33.572025+3.2%/yr
Current ratio2.4720161.032025−1.45
Debt / equity0.3920160.592025+0.20
Shares outstanding2.79B20162.43B2025−1.5%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

JNJ assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

JNJ liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

JNJ debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

JNJ balance sheet

Johnson & Johnson annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$20.10B$24.52B$22.93B$22.28B$31.61B$25.18B$19.29B$19.69B$18.30B$41.91B
Cash & equivalents$19.71B$24.11B$21.86B$12.89B$14.49B$13.98B$17.30B$18.11B$17.82B$18.97B
Short-term investments$393.0M$417.0M$1.07B$9.39B$17.12B$11.20B$1.98B$1.58B$472.0M$22.93B
Receivables$17.18B$18.93B$14.87B$16.91B$18.98B$13.58B$14.48B$14.10B$13.49B$11.70B
Inventory$14.19B$12.44B$11.18B$10.27B$10.39B$9.34B$9.02B$8.60B$8.77B$8.14B
Other current assets$4.15B$0$4.51B$5.83B$0$3.13B$2.49B$3.65B$2.54B$3.28B
Total current assets$55.62B$55.89B$53.49B$55.29B$60.98B$51.24B$45.27B$46.03B$43.09B$65.03B
Property, plant & equipment (net)$23.17B$20.52B$19.90B$17.98B$18.96B$18.77B$17.66B$17.04B$17.00B$15.91B
Goodwill & intangible assets$99.17B$81.82B$70.73B$74.54B$81.64B$89.80B$81.28B$78.06B$85.13B$49.68B
Long-term investments$0$0$0$0$0$0$1.15B$517.0M$758.0M$900.0M
Other non-current assets$21.24B$21.88B$23.43B$39.57B$20.44B$15.10B$12.37B$11.30B$11.32B$9.68B
Total assets$199.21B$180.10B$167.56B$187.38B$182.02B$174.89B$157.73B$152.95B$157.30B$141.21B
Liabilities
Accounts payable$11.99B$10.31B$9.63B$9.89B$11.05B$9.51B$8.54B$7.54B$7.31B$6.92B
Short-term debt$8.49B$5.98B$3.45B$12.76B$3.77B$2.63B$1.20B$2.80B$3.91B$4.68B
Deferred revenue——$2.99B———$7.82B$7.64B$1.85B$6.15B
Total current liabilities$54.13B$50.32B$46.28B$55.80B$45.23B$42.49B$35.96B$31.23B$30.54B$26.29B
Long-term debt$39.44B$30.65B$25.88B$26.89B$29.98B$32.63B$26.49B$27.68B$30.68B$22.44B
Other long-term liabilities$24.10B$27.64B$26.62B$27.88B$32.78B$36.49B$35.80B$34.29B$35.93B$22.06B
Total liabilities$117.67B$108.61B$98.78B$110.57B$108.00B$111.62B$98.26B$93.20B$97.14B$70.79B
Shareholders' equity
Common stock & paid-in capital$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B
Retained earnings (deficit)$168.98B$155.79B$153.84B$128.34B$123.06B$113.89B$110.66B$106.22B$101.79B$110.55B
Treasury stock——−$75.66B−$41.69B−$39.10B−$38.49B−$38.42B−$34.36B−$31.55B−$28.35B
Accumulated other comprehensive income−$14.93B−$11.74B−$12.53B−$12.97B−$13.06B−$15.24B−$15.89B−$15.22B−$13.20B−$14.90B
Minority interest——$0$0$0$0$0$0$0$0
Total shareholders' equity$81.54B$71.49B$68.77B$76.80B$74.02B$63.28B$59.47B$59.75B$60.16B$70.42B
Key figures
Total debt$47.93B$36.63B$29.33B$39.64B$33.75B$35.27B$27.70B$30.48B$34.58B$27.13B
Net cash (debt)−$27.83B−$12.11B−$6.41B−$17.36B−$2.14B−$10.08B−$8.41B−$10.79B−$16.29B$14.78B
Working capital$1.50B$5.57B$7.21B−$508.0M$15.75B$8.74B$9.31B$14.80B$12.55B$38.74B
Tangible book value−$17.63B−$10.33B−$1.96B$2.27B−$7.62B−$26.52B−$21.81B−$18.31B−$24.97B$20.74B
Book value per share$33.57$29.43$26.86$28.83$27.68$23.69$22.16$21.90$21.91$25.25
Shares outstanding2.43B2.43B2.56B2.66B2.67B2.67B2.68B2.73B2.75B2.79B
Current ratio1.031.111.160.991.351.211.261.471.412.47
Quick ratio0.690.860.820.701.120.910.941.081.042.04
Debt / equity0.590.510.430.520.460.560.470.510.570.39
Equity / assets40.9%39.7%41.0%41.0%40.7%36.2%37.7%39.1%38.2%49.9%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 11, 2026); data from EODHD.

JNJ financial position

At the end of fiscal 2025 (December 31, 2025), Johnson & Johnson had total assets of $199.2 billion (up 10.6% from a year earlier), total liabilities of $117.7 billion and shareholders' equity of $81.5 billion. It held $20.1 billion in cash and short-term investments against $47.9 billion of debt, net debt of $27.8 billion. Its current ratio was 1.03. In the latest quarter (ended June 30, 2026) total assets were $201.1 billion and equity $85.0 billion.

Related: JNJ income statement, JNJ cash flow statement, JNJ key metrics. See the JNJ stock overview for the latest quote and news.

JNJ balance sheet FAQ

What are Johnson & Johnson's total assets?

Johnson & Johnson reported total assets of $199.2 billion at the end of fiscal 2025 (December 31, 2025), compared with $180.1 billion a year earlier.

How much debt does Johnson & Johnson have?

Johnson & Johnson had $47.9 billion of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.59.

How much cash does Johnson & Johnson have?

Johnson & Johnson held $20.1 billion in cash and short-term investments at the end of fiscal 2025; with $47.9 billion of debt that is net debt of $27.8 billion.

What is Johnson & Johnson's book value?

Johnson & Johnson's shareholders' equity (book value) was $81.5 billion at the end of fiscal 2025, or $33.57 per share.

What is Johnson & Johnson's current ratio?

Johnson & Johnson had current assets of $55.6 billion and current liabilities of $54.1 billion, a current ratio of 1.03 (it can cover its short-term obligations).

How much goodwill does Johnson & Johnson have?

Johnson & Johnson carried $99.2 billion of goodwill and intangible assets, 49.8% of total assets, at the end of fiscal 2025.

Drug Manufacturers - General: balance sheet